Ursprung des Netzwerks ersten Grades von Deepali Suri
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 35 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Deepali Suri
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SUMMIT THERAPEUTICS INC. | Biotechnology | Chief Executive Officer Director/Board Member Director of Finance/CFO Chief Executive Officer Director/Board Member General Counsel Chief Tech/Sci/R&D Officer | |
Pharmacyclics, Inc.
 Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Chief Operating Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| PULSE BIOSCIENCES, INC. | Medical Specialties | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Compliance Officer | |
| BIOMEA FUSION, INC. | Pharmaceuticals: Major | Founder Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Robert W. Duggan & Associates
 Robert W. Duggan & Associates Investment ManagersFinance Robert W. Duggan & Associates provides investment advisory services. The firm also offers portfolio management, financial planning, and consulting services. The company was founded by Robert W. Duggan and is headquartered in Santa Barbara, CA. | Investment Managers | Founder Corporate Officer/Principal Corporate Officer/Principal | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Compliance Officer | |
| KITE PHARMA INC | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Sales & Marketing | |
| ZELTIQ AESTHETICS INC | Medical Specialties | Director of Finance/CFO Director of Finance/CFO | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Maky Zanganeh & Associates, Inc. | Founder General Counsel | ||
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| INTUITIVE SURGICAL, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| CORVUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
| Hamilton College (New York) | College/University | Undergraduate Degree Undergraduate Degree | |
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal General Counsel | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| University of California, Santa Barbara | College/University | Graduate Degree Graduate Degree | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
| University of California, Los Angeles | College/University | Doctorate Degree Masters Business Admin | |
Point Sur Investors LLC
 Point Sur Investors LLC Investment ManagersFinance Point Sur Investors LLC provides investment advice. The private company is based in El Cerrito, CA and has subsidiaries in the United States. The company was founded in 2015 by Thomas Butler, Rainer M. Erdtmann. | Investment Managers | Founder Founder | |
University of California Santa Barbara Foundation
 University of California Santa Barbara Foundation Investment Trusts/Mutual FundsMiscellaneous University of California Santa Barbara Foundation engages in the provision of management and investment services inside the campus. The company was founded in 1973 and is headquartered in Santa Barbara, CA. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
Human Longevity, Inc.
 Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Lassen Therapeutics LLC
 Lassen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Lassen Therapeutics LLC operates as a therapeutic antibody company. It discovers and develops novel medicines to treat serious unmet medical needs. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Chief Operating Officer | |
| Acerta Pharma LLC | Chief Operating Officer | ||
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Pharmaceuticals: Major | Director/Board Member | |
| University of Illinois At Urbana–Champaign | College/University | Undergraduate Degree | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor | |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
| CRISPR THERAPEUTICS AG | Biotechnology | Director/Board Member | |
| St. Francis Xavier University | College/University | Undergraduate Degree | |
Quanta Therapeutics, Inc.
 Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
| LEXICON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARVINAS, INC. | Biotechnology | Corporate Officer/Principal | |
| University of California, Santa Cruz | College/University | Undergraduate Degree | |
Biosplice Therapeutics, Inc.
 Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| Moffit Cancer Center | Corporate Officer/Principal | ||
| The University of Texas Medical School At Houston | College/University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 46 |
| Vereinigtes Königreich | 2 |
| Niederlande | 2 |
| Schweiz | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 33 |
| Consumer Services | 8 |
| Finance | 4 |
| Commercial Services | 3 |
| Miscellaneous | 2 |
Operativ
| Director/Board Member | 100 |
| Corporate Officer/Principal | 86 |
| Independent Dir/Board Member | 46 |
| Undergraduate Degree | 27 |
| Chief Tech/Sci/R&D Officer | 26 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Lori Kunkel | 27 |
| Shawn Tomasello | 22 |
| Robert Duggan | 18 |
| Maria Fardis | 15 |
| Diane Parks | 14 |
| Eric H. Halvorson | 14 |
| Mahkam Zanganeh | 14 |
| Richard van den Broek | 14 |
| Manmeet Singh Soni | 13 |
| Ramses Erdtmann | 13 |
| Elizabeth Faust | 12 |
| Elaine C. Stracker | 12 |
| Joshua Brumm | 11 |
| Gregory R. Wade | 10 |
| Roy C. Hardiman | 9 |
- Börse
- Insiders
- Deepali Suri
- Unternehmensverbindungen